Fondaparinux Sodium (Xa Inhibition)

Understand what Fondaparinux Sodium (Xa Inhibition) signals

LOINC codes: 49060-7
Commercial laboratory assays: 1

We have not added a physiological summary for this biomarker yet. Compare the commercial laboratory assays and population reference ranges below.

Compare commercial laboratory assays for Fondaparinux Sodium (Xa Inhibition)

Check orderable catalog codes, specimen types, fasting requirements, and demographic reference ranges across laboratories.

Fondaparinux Sodium (Xa Inhibition)

Laboratory: Quest Diagnostics
Test code: 16103
Specimen: Plasma
Fasting: Not stated
LOINC: 49060-7
Turnaround: Set up: Wed

Laboratory assay overview

Fondaparinux sodium (Arixtra) is a factor Xa inhibitor indicated for the prophylaxis and treatment of deep venous thrombosis and pulmonary embolism in certain patient populations. The antithrombotic activity of Arixtra is the result of antithrombin III-mediated selective inhibition of Factor Xa. Neutralization of factor Xa interrupts thrombin formation and thrombus development. The anti-Factor Xa activity of the drug can be measured using the chromogenic anti-Xa method using Arixtra as the calibrator.

View complete laboratory reference notes

Not established

Quest Diagnostics test directory, test code 16103

Verify these ranges and sources

We compile every detail above directly from named laboratory directories and published clinical studies. Laboratories calculate standard reference intervals from the statistical distribution of tested populations for a specific assay method and demographic group, rather than setting universal optimal targets.

Always review your personal lab results with a licensed clinician, or track your lab history and health goals in Aumnivida.

Spotted an error? Email hello@biomarkerlens.com with the page URL and the primary source that corrects the entry.